Local Institution

Sherbrooke, Quebec J1H 5N4

0 studies enrolling now · 11 studies all time

What they study most

Acute Coronary Syndromes, Cancer of the Stomach, Diabetes Mellitus, Diabetes Mellitus II, Diabetes Mellitus, Type 2, Gastric Cancer, Gastroesophageal Junction, Non Small Cell Lung Cancer, Prostatic Neoplasms, Rheumatoid Arthritis, Stomach Cancer, Type 2 Diabetes

Studies at this site

• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
• A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes — Completed
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment — Completed
• Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer — Completed
• A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC — Completed
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin — Completed
• Abatacept With Methotrexate- Phase IIB — Completed
• PPAR - Combination With Metformin — Completed
• Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed